Gene · 49
NIH grants1,192
NIH grants whose papers are about the gene, through NIH's grant-paper links.
261 to 280 of 1,192
Download this page as JSON| Grant | Title | ACR papers | Newest fiscal year |
|---|---|---|---|
| U19AI062629 | Molecular and Immunologic Analysis of the Pathobiology of Human Anthrax | 3 | 2023 |
| ZIADK069062 | Epidemiology, Pathophysiology and Treatment of Diabetic Nephropathy | 3 | 2023 |
| K12HD043451 | Building Interdisciplinary Research Careers in Women's Health | 2 | 2023 |
| R01DK098234 | Kidney Tubular Damage and Dysfunction Identify a Novel Axis of Chronic Kidney Disease | 2 | 2023 |
| RF1NS133657 | Developing an Optogenetics Technology Based on Natural Potassium-selective Channelrhodopsins | 2 | 2023 |
| U01NS118288 | Molecular Engineering of Natural Light-Gated Chloride Channels for Optogenetic Inhibition | 2 | 2023 |
| U54DK083912 | Nephrotic Syndrome Rare Disease Clinical Research Network III | 2 | 2023 |
| UL1TR001420 | Wake Forest Clinical and Translational Science Award | 2 | 2023 |
| D43TW010937 | University of Pittsburgh HIV-Comorbidities Research Training Program in South Africa | 1 | 2023 |
| I01BX004660 | Pathogenic Role of Malondialdehyde-Acetaldehyde Adducts in Rheumatoid Arthritis | 1 | 2023 |
| I01RX002790 | Effects of 12-weeks of High-intensity Resistance Aerobic Circuit Exercise Training on Epigenetic Aging and Inflammation in Older HIV-infected Veterans | 1 | 2023 |
| K01AG064041 | A Feasibility and Pilot Study of Combined Treatment Protocol using Aerobic Exercise and Duloxetine in Older Adults with Symptomatic Knee Osteoarthritis and Comorbid Depression | 1 | 2023 |
| K01ES032015 | Women's airborne exposure and kidney health in Guatemala | 1 | 2023 |
| K08CA230157 | Role of tumor burden in limiting durable reinvigoration by PD-1 blockade | 1 | 2023 |
| K12HD043483 | Building Interdisciplinary Research Careers in Women's Health | 1 | 2023 |
| K23AR075872 | Understanding Inflammatory Arthritis due to Immune Checkpoint Inhibitors | 1 | 2023 |
| K23AR075898 | Optimizing the Approach to Identify Cancer-Associated Myositis | 1 | 2023 |
| K23EY030158 | Ophthalmic Disease and Laboratory Surveillance in a Viral Hemorrhagic Fever Zone | 1 | 2023 |
| K24HL148181 | Patient-Oriented Research Addressing Disparities in Hypertension and Kidney Disease | 1 | 2023 |
| K99GM144742 | Exploration of cis-regulatory diversity underlying phenotypic innovation | 1 | 2023 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/49/grants?page=14